Search Orphan Drug Designations and Approvals
-
Generic Name: | Humanized Recombinant IgG4 Anti-PD-1 Monoclonal Antibody |
---|---|
Date Designated: | 07/14/2020 |
Orphan Designation: | Treatment of hepatocellular carcinoma |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
CStone Pharmaceuticals (Suzhou) Co., Ltd. 1000 Zhangheng Road Building 25 Shanghai 201203 China The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-